Donate For Public and Patients Store Search

American Academy of Dermatology Logo

Dermatology World

CBD: Potential or placebo?

Despite the explosion in popularity of cannabinoid products, many questions remain regarding their efficacy and long-term use. DW investigates potential applications and concerns regarding the use of cannabinoids in dermatology.

Not what the doctor ordered?

Most dermatologists have good relationships with their patients’ pharmacists, but there can be bumps in the road due to miscommunication, lack of communication, and inadequate education of pharmacists about dermatologic conditions.

Leading by serving

“Good leadership is not about being in charge, it’s about taking care of those in your charge.” Learn if the servant leadership model right for you.

Cracking the Code
Cracking the Code

Alex Miller, MD, offers a review of Mohs qualifying, documentation, and billing criteria.

art for Clinical Applications
Clinical Applications

Esther Freeman, MD, PhD, discusses the new COVID-19 Dermatology Registry.

Answers in Practice

James Zalla, MD, discusses his efforts to keep his practice afloat during the COVID-19 pandemic.

Facts at Your Fingertips

DW offers a snapshot on the burden of prior authorization in the United States.

Legally Speaking

Are you exempt from the COVID-19 FMLA and paid sick leave provisions?

Locked in

Will your non-compete dictate where you practice next?

Legally Speaking

What do you need to know about employment laws when considering a staff furlough?

That’s not me!

How to protect yourself from physician identity theft.

From the Editor

Physician editor Kathryn Schwarzenberger, MD, previews this month’s issue.

What’s Hot?

Members of DW’s Editorial Advisory Workgroup share exciting news from across the specialty.

Asked & Answered

What resources does the Academy have on telemedicine?

From the president

Academy President Bruce Thiers, MD, offers his thoughts on rebuilding after COVID-19.

Additional Dermatology World Resources